Concepedia

Publication | Open Access

Apixaban 5 and 2.5 mg twice-daily versus warfarin for stroke prevention in nonvalvular atrial fibrillation patients: Comparative effectiveness and safety evaluated using a propensity-score-matched approach

37

Citations

33

References

2018

Year

Abstract

Clinicaltrials.Gov Identifier: NCT03087487.

References

YearCitations

Page 1